NL8702007A - Nieuwe met tritium gemerkte verbinding, haar bereiding en haar toepassing in het bijzonder bij de bepaling van de affiniteit van de retinoiden voor hun celreceptor. - Google Patents

Nieuwe met tritium gemerkte verbinding, haar bereiding en haar toepassing in het bijzonder bij de bepaling van de affiniteit van de retinoiden voor hun celreceptor. Download PDF

Info

Publication number
NL8702007A
NL8702007A NL8702007A NL8702007A NL8702007A NL 8702007 A NL8702007 A NL 8702007A NL 8702007 A NL8702007 A NL 8702007A NL 8702007 A NL8702007 A NL 8702007A NL 8702007 A NL8702007 A NL 8702007A
Authority
NL
Netherlands
Prior art keywords
tritium
tetrahydro
tetramethyl
naphthyl
benzo
Prior art date
Application number
NL8702007A
Other languages
English (en)
Dutch (nl)
Original Assignee
Cird
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird filed Critical Cird
Publication of NL8702007A publication Critical patent/NL8702007A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
NL8702007A 1986-08-29 1987-08-27 Nieuwe met tritium gemerkte verbinding, haar bereiding en haar toepassing in het bijzonder bij de bepaling van de affiniteit van de retinoiden voor hun celreceptor. NL8702007A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8612237A FR2603280B1 (fr) 1986-08-29 1986-08-29 Nouveau compose marque au tritium, sa preparation et son application notamment dans la determination de l'affinite des retinoides pour leur recepteur cellulaire
FR8612237 1986-08-29

Publications (1)

Publication Number Publication Date
NL8702007A true NL8702007A (nl) 1988-03-16

Family

ID=9338587

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8702007A NL8702007A (nl) 1986-08-29 1987-08-27 Nieuwe met tritium gemerkte verbinding, haar bereiding en haar toepassing in het bijzonder bij de bepaling van de affiniteit van de retinoiden voor hun celreceptor.

Country Status (11)

Country Link
US (1) US4880941A (sv)
JP (1) JPS63152376A (sv)
BE (1) BE1004153A3 (sv)
CA (1) CA1293733C (sv)
CH (1) CH673028A5 (sv)
DE (1) DE3728810C2 (sv)
FR (1) FR2603280B1 (sv)
GB (1) GB2194535B (sv)
IT (1) IT1228949B (sv)
NL (1) NL8702007A (sv)
SE (1) SE463714B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635683B1 (fr) * 1988-09-01 1990-11-09 Cird Nouveau compose marque au tritium, sa preparation et son application notamment dans la determination de l'affinite des retinoides pour leurs recepteurs nucleaires et leur proteine de liaison cytosolique
US5149631A (en) * 1989-07-20 1992-09-22 Centre International De Recherches Dermatologiques Galderma (Cird Galderma) Compound marked with tritium, its preparation and its use in the location of nuclear receptors of retinoids
FR2649976B1 (fr) * 1989-07-20 1991-09-27 Cird Nouveau compose marque au tritium, sa preparation et son application notamment dans le reperage des recepteurs nucleaires des retinoides
EP0999271A3 (en) * 1990-02-09 2003-04-02 The Salk Institute For Biological Studies Retinoid receptor compositions and methods
US5641652A (en) * 1990-03-22 1997-06-24 The Salk Institute For Biological Studies Insect retinoid-like receptor compositions and methods
US5508456A (en) * 1993-07-30 1996-04-16 Ligand Pharmaceuticals Incorporated 9-cis tritium-labeled retinoids and intermediates, methods for their synthesis and methods for their use in discovering retinoid X receptor ligands
WO1995011217A1 (en) * 1993-10-22 1995-04-27 Ligand Pharmaceuticals Incorporated Isotopically-labeled retinoids, their production and use
TW200404054A (en) * 2002-07-26 2004-03-16 Wako Pure Chem Ind Ltd Method for deuteration of aromatic ring
TW200413273A (en) * 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
TW200413274A (en) * 2002-12-27 2004-08-01 Wako Pure Chem Ind Ltd Deuteration or tritiation method
WO2005070853A1 (ja) * 2004-01-23 2005-08-04 Wako Pure Chemical Industries, Ltd. 混合触媒を用いた重水素化方法
GB201517745D0 (en) * 2015-10-07 2015-11-18 Johnson Matthey Plc Method of monitoring a parameter of a hydrocarbon well, pipeline or formation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3142975A1 (de) * 1981-10-29 1983-05-11 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur herstellung von mit tritium markierterretinsaeure
LU85544A1 (fr) * 1984-09-19 1986-04-03 Cird Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique

Also Published As

Publication number Publication date
GB8720397D0 (en) 1987-10-07
SE8703336L (sv) 1988-03-01
DE3728810A1 (de) 1988-03-03
US4880941A (en) 1989-11-14
GB2194535A (en) 1988-03-09
CA1293733C (fr) 1991-12-31
DE3728810C2 (de) 1998-02-26
IT1228949B (it) 1991-07-10
CH673028A5 (sv) 1990-01-31
FR2603280A1 (fr) 1988-03-04
BE1004153A3 (fr) 1992-10-06
FR2603280B1 (fr) 1988-10-28
IT8721749A0 (it) 1987-08-28
SE8703336D0 (sv) 1987-08-28
SE463714B (sv) 1991-01-14
JPS63152376A (ja) 1988-06-24
GB2194535B (en) 1990-03-21

Similar Documents

Publication Publication Date Title
Lewis et al. Identification of the C (6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activity
NL8702007A (nl) Nieuwe met tritium gemerkte verbinding, haar bereiding en haar toepassing in het bijzonder bij de bepaling van de affiniteit van de retinoiden voor hun celreceptor.
Seimbille et al. 18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals
Ortmeyer et al. Synthesis and evaluation of a [18F] BODIPY-labeled caspase-inhibitor
Dai et al. Prediction of partition coefficient and toxicity for benzaldehyde compounds by their capacity factors and various molecular descriptors
Pirkle et al. Chiral recognition studies: Intra-and intermolecular 1H {1H}-nuclear overhauser effects as effective tools in the study of bimolecular complexes
Zhang et al. Synthesis and evaluation of N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F] fluoromethoxy-d2-5-methoxybenzyl) acetamide: a deuterium-substituted radioligand for peripheral benzodiazepine receptor
US5196577A (en) Compound marked with tritium, its preparation and its use in particular in the determination of the affinity of retinoids for their nuclear receptors and their cytosolic binding protein
Yen et al. Development and validation of high performance liquid chromatographic method for determination of gentisic acid and related renal cell carcinoma biomarkers in urine
Darby et al. 7. alpha.-Substituted derivatives of androstenedione as inhibitors of estrogen biosynthesis
EP0409740B1 (fr) Nouveau composé marqué au tritium, sa préparation et son application, notamment dans le repérage des récepteurs nucléaires des rétinoides
AU5215100A (en) Methods for preparing perfluorinated (18F)-radiolabelled nitroimidazole derivatives for cellular hypoxia detection
Santa et al. N-(4-nitro-2, 1, 3-benzoxadiazoyl-7-yl)-N-methyl-2-aminoacetohydrazide (NBD-CO-Hz) as a precolumn fluorescent derivatization reagent for carboxylic acids in high-performance liquid chromatography
Alvarez et al. C3 halogen and c8′′ substituents on stilbene arotinoids modulate retinoic acid receptor subtype function
Cole et al. The Value of In Vitro Binding as Predictor of In Vivo Results: A Case for [18 F] FDDNP PET
Guarna et al. Synthesis and preliminary biological characterization of a new potential 125I-Radioligand for dopamine and serotonin receptors
TANAKA et al. Analytical studies on mepirizole and its metabolites. IV. Quantitative determination of mepirizole in human serum by mass fragmentography, and isotope effect on drug metabolism
Ogata et al. Radiosynthesis of [11C] MNS for PET imaging of NLRP3 inflammasome with [11C] nitromethane in one-pot and its evaluation in rat brains
Timmers et al. A rapid versatile microassay for cellular retinol-binding protein using Lipidex-1000 microcolumns.
Huang et al. Direct detection of nitric oxide in human blood serum by use of 1, 3, 5, 7-tetramethyl-8-(3′, 4′-diaminophenyl) difluoroboradiaza-s-indacene with HPLC
Zeitler et al. Improved Preparation and Structural Elucidation of the Tryptophan Cleavage Reagent 2-(2′-Nitro-phenylsulfenyl)-3-methyl-3-bromoindolenine (BNPS-skatole)
Brown-Proctor et al. Synthesis and in vivo evaluation of (E)-N-[11C] methyl-4-(3-pyridinyl)-3-butene-1-amine ([11C] metanicotine) as a nicotinic receptor radioligand
Burns et al. The preparation of carbon‐14 and tritium labelled 1‐[4‐(2‐dimethylaminoethoxy) phenyl]‐1, 2‐diphenyl‐1‐butene [ICI 46,474, tamoxifen (nolvadex)] and the separation of cis‐trans isomers 2. The synthesis of tritium labelled tamoxifen (nolvadex)
Zawirska Neoplasms and metabolic disturbances of porphyrins in rats with chronic experimental lead poisoning
Aboul-Enein Glutethimide

Legal Events

Date Code Title Description
BV The patent application has lapsed